Filing Flows › Cosmos Health (COSM) › R&D spending
Cosmos Health (COSM) R&D spending by quarter
Cosmos Health's R&D spending was $69K in Q2 2026 (second quarter 2026), -83% from Q4 2025. Over the last 6 quarters it ranged from $16K (Q1 2025) to $533K (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $69K | -83% | -8% |
| Q4 2025 | $411K | 22× | -23% |
| Q3 2025 | $18K | -75% | — |
| Q2 2025 | $75K | +378% | — |
| Q1 2025 | $16K | -97% | — |
| Q4 2024 | $533K | — | — |
Q2 2026 at a glance
Cosmos Health, Q2 2026: revenue $19.0M (+29% year over year), operating margin -15.4%, net loss $6.1M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cosmos Health's R&D spending?
Cosmos Health's R&D spending was $69K in Q2 2026 (second quarter 2026), -83% from Q4 2025.
How has Cosmos Health's R&D spending changed?
Over the last 6 quarters it ranged from $16K (Q1 2025) to $533K (Q4 2024).